Lotrimin Af
cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.
18,003 recalls, newest first
cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.
cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.
cGMP Deviations: manufactured at the same facility where other lots were found to be contaminated with benzene.
cGMP Deviations
cGMP Deviations
cGMP Deviations
Chemical contamination; presence of benzene
Chemical contamination; presence of benzene
Chemical contamination; presence of benzene
Chemical contamination; presence of benzene
Chemical contamination; presence of benzene
Labeling; Label mix-up and Wrong Bar Code; back label incorrectly states active ingredient as Menthol with UPC 7 14132 00071 4 instead of Peppermint Oil and Sage Oil with UPC 7 14132 00073 8
Labeling: Not Elsewhere Classified: the controlled substance classification "CIII" is missing on the label
Labeling: Not Elsewhere Classified: the controlled substance classification "CIII" is missing on the label
Failed Dissolution Specifications
Lack of Assurance of Sterility: Air filter failed post integrity test leading to a lack of sterility assurance.
SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance. There was also a lack of full drug effect upon administration.
Finished product specification did not meet USP specifications.
Lack of Assurance of Sterility
Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol
Lack of Assurance of Sterility